Research ArticleNuclear Oncology
Iodine-131 Therapy in Sporadic Nontoxic Goiter
John M.H. de Klerk, Johannes W. van Isselt, Aalt van Dijk, Marc E. Hakman, Frank A. Pameijer, Hans P.F. Koppeschaar, Pierre M.J. Zelissen, Jan P.J. van Schaik and Peter P. van Rijk
Journal of Nuclear Medicine March 1997, 38 (3) 372-376;
John M.H. de Klerk
Johannes W. van Isselt
Aalt van Dijk
Marc E. Hakman
Frank A. Pameijer
Hans P.F. Koppeschaar
Pierre M.J. Zelissen
Jan P.J. van Schaik


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Iodine-131 Therapy in Sporadic Nontoxic Goiter
John M.H. de Klerk, Johannes W. van Isselt, Aalt van Dijk, Marc E. Hakman, Frank A. Pameijer, Hans P.F. Koppeschaar, Pierre M.J. Zelissen, Jan P.J. van Schaik, Peter P. van Rijk
Journal of Nuclear Medicine Mar 1997, 38 (3) 372-376;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy
- Dosimetry of Radioiodine Therapy in Patients with Nodular Goiter After Pretreatment with a Single, Low Dose of Recombinant Human Thyroid-Stimulating Hormone
- 131I Therapy: Inpatient or Outpatient?